A first-of-its-kind trial is testing adult stem cell transplants for advanced dry macular degeneration. Early results show ...
The FDA approved Eylea HD for the treatment of macular edema following retinal vein occlusion, according to a press ...
University of Minnesota Medical School researchers have shown that reducing chronic inflammation can significantly protect against age-related macular degeneration (AMD)-like pathology in preclinical ...
A wireless implant helped patients with severe macular degeneration regain usable vision. The results point toward a new ...
The FDA has approved Eylea HD (aflibercept) 8 mg to treat patients with macular edema following retinal vein occlusion (RVO) with dosing of up to every 8 weeks after an initial monthly dosing period.
First and only FDA-approved treatment for RVO indicated for up to every 8-week dosing after an initial monthly dosing period Monthly dosing ...
No changes in protocol recommended for LUGANO and LUCIA clinical trials –– Masked safety data continues to show no safety signals, consistent ...
A new study in The New England Journal of Medicine revealed that the PRIMA brain computer interface (BCI) retinal implant helped people with advanced age-related macular degeneration regain some ...
A clinical trial led by Stanford University School of Medicine has demonstrated that a wireless retinal prosthesis can help restore vision lost to advanced macular degeneration. The results, published ...
The device could help a million people with a severe form of macular degeneration to be able to see enough to read. By Gina Kolata For the first time, researchers restored some vision to people with a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback